Variant report

Variant	nsv970360
Chromosome Location	chr6:167658198-167678399
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr6:167669429-167669771	K562	blood:	n/a	n/a
2	CEBPB	chr6:167658239-167658916	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr6:167665707-167665869	HepG2	liver:	n/a	chr6:167665793-167665804
4	CHD2	chr6:167661782-167661982	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr6:167669440-167669590	RPTEC	kidney:	n/a	n/a
6	CTCF	chr6:167669520-167669670	HEK293	kidney:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
7	CTCF	chr6:167669473-167669717	HepG2	liver:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
8	CTCF	chr6:167669560-167669710	BE2_C	brain:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
9	CTCF	chr6:167669440-167669590	HCM	heart:	n/a	n/a
10	CTCF	chr6:167669440-167669590	BE2_C	brain:	n/a	n/a
11	CTCF	chr6:167669565-167669684	Hela-S3	cervix:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
12	CTCF	chr6:167661340-167661490	HEK293	kidney:	n/a	n/a
13	CTCF	chr6:167661760-167661910	HepG2	liver:	n/a	chr6:167661854-167661872
14	CTCF	chr6:167669580-167669730	NB4	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
15	CTCF	chr6:167661782-167662019	K562	blood:	n/a	chr6:167661854-167661872
16	CTCF	chr6:167669500-167669650	HRPEpiC	eye:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
17	CTCF	chr6:167669520-167669670	GM12865	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
18	CTCF	chr6:167669460-167669610	A549	lung:	n/a	n/a
19	CTCF	chr6:167669520-167669670	GM12873	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
20	CTCF	chr6:167661516-167661551	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr6:167658580-167658730	Caco-2	colon:	n/a	n/a
22	CTCF	chr6:167669380-167669530	RPTEC	kidney:	n/a	n/a
23	CTCF	chr6:167669520-167669670	GM12875	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
24	CTCF	chr6:167669560-167669710	GM12870	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
25	CTCF	chr6:167669500-167669650	GM12878	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
26	CTCF	chr6:167661740-167661890	HEK293	kidney:	n/a	chr6:167661854-167661872
27	CTCF	chr6:167669600-167669750	GM06990	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
28	CTCF	chr6:167669860-167670010	K562	blood:	n/a	n/a
29	CTCF	chr6:167669540-167669690	K562	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
30	CTCF	chr6:167661768-167661950	HepG2	liver:	n/a	chr6:167661854-167661872
31	CTCF	chr6:167661780-167661930	BE2_C	brain:	n/a	chr6:167661854-167661872
32	CTCF	chr6:167661760-167661910	HCT-116	colon:	n/a	chr6:167661854-167661872
33	CTCF	chr6:167669600-167669750	GM12872	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
34	CTCF	chr6:167669540-167669690	GM12871	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
35	CTCF	chr6:167658640-167658790	WERI-Rb-1	eye:	n/a	n/a
36	CTCF	chr6:167673874-167673946	Kidney_OC	kidney:	n/a	n/a
37	CTCF	chr6:167661760-167661910	SK-N-SH_RA	brain:	n/a	chr6:167661854-167661872
38	CTCF	chr6:167669560-167669710	GM12864	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
39	CTCF	chr6:167658660-167658810	HEK293	kidney:	n/a	n/a
40	CTCF	chr6:167669480-167669630	GM12873	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
41	CTCF	chr6:167669428-167669772	K562	blood:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
42	CTCF	chr6:167669520-167669670	SK-N-SH_RA	brain:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
43	CTCF	chr6:167669460-167669610	HCT-116	colon:	n/a	n/a
44	CTCF	chr6:167669580-167669730	HepG2	liver:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
45	CTCF	chr6:167669620-167669770	Caco-2	colon:	n/a	n/a
46	CTCF	chr6:167669560-167669710	HFF-Myc	foreskin:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
47	CTCF	chr6:167661860-167662010	K562	blood:	n/a	n/a
48	CTCF	chr6:167669519-167669704	HepG2	liver:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
49	CTCF	chr6:167669520-167669670	WERI-Rb-1	eye:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619
50	CTCF	chr6:167669411-167669730	HepG2	liver:	n/a	chr6:167669607-167669617 chr6:167669602-167669620 chr6:167669604-167669625 chr6:167669603-167669619

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:167658907-167658957	ECC-1	luminal epithelium:	n/a
2	chr6:167661905-167661955	AG10803	skin:	n/a
3	chr6:167661905-167661955	HL-60	blood:	n/a
4	chr6:167661905-167661955	AG09319	gingival:	n/a
5	chr6:167658907-167658957	Jurkat	blood:	n/a
6	chr6:167661905-167661955	HepG2	liver:	n/a
7	chr6:167658907-167658957	HCF	heart:	n/a
8	chr6:167661905-167661955	HCT-116	colon:	n/a
9	chr6:167658907-167658957	HPAEpiC	pulmonary alveolar:	n/a
10	chr6:167661905-167661955	AoSMC	blood vessel:	n/a
11	chr6:167661905-167661955	AG04450	lung:	fetal
12	chr6:167661905-167661955	HRPEpiC	eye:	n/a
13	chr6:167658907-167658957	NT2-D1	testis:	n/a
14	chr6:167661905-167661955	GM12878	blood:	n/a
15	chr6:167661905-167661955	NT2-D1	testis:	n/a
16	chr6:167661905-167661955	NHDF-neo	bronchial:	n/a
17	chr6:167661905-167661955	Hela-S3	cervix:	n/a
18	chr6:167658907-167658957	K562	blood:	n/a
19	chr6:167658907-167658957	HCPEpiC	choroid plexus:	n/a
20	chr6:167661905-167661955	CMK	blood:	n/a
21	chr6:167661905-167661955	HCPEpiC	choroid plexus:	n/a
22	chr6:167658907-167658957	NHDF-neo	bronchial:	n/a
23	chr6:167658907-167658957	MCF10A-Er-Src	breast:	n/a
24	chr6:167661905-167661955	BJ	skin:	n/a
25	chr6:167658907-167658957	Hepatocyte	liver:	n/a
26	chr6:167658907-167658957	NH-A	brain:	n/a
27	chr6:167658907-167658957	PANC-1	pancreas:	n/a
28	chr6:167661905-167661955	PFSK-1	brain:	n/a
29	chr6:167661905-167661955	K562	blood:	n/a
30	chr6:167661905-167661955	NHBE	bronchial:	n/a
31	chr6:167661905-167661955	GM12892	blood:	n/a
32	chr6:167658907-167658957	ovcar-3	ovarian:	n/a
33	chr6:167661905-167661955	PANC-1	pancreas:	n/a
34	chr6:167661905-167661955	NH-A	brain:	n/a
35	chr6:167661905-167661955	SK-N-SH_RA	brain:	n/a
36	chr6:167658907-167658957	HEK293	kidney:	embryo
37	chr6:167661905-167661955	SAEC	small airway:	n/a
38	chr6:167658907-167658957	CMK	blood:	n/a
39	chr6:167661905-167661955	Hepatocyte	liver:	n/a
40	chr6:167658907-167658957	HCM	heart:	n/a
41	chr6:167658907-167658957	SK-N-SH	brain:	n/a
42	chr6:167661905-167661955	HEEpiC	esophagus:	n/a
43	chr6:167658907-167658957	Caco-2	colon:	n/a
44	chr6:167658907-167658957	LNCaP	prostate:	n/a
45	chr6:167661905-167661955	GM19239	blood:	n/a
46	chr6:167661905-167661955	Jurkat	blood:	n/a
47	chr6:167658907-167658957	HL-60	blood:	n/a
48	chr6:167661905-167661955	H1-hESC	embryonic stem cell:	embryo
49	chr6:167661905-167661955	ovcar-3	ovarian:	n/a
50	chr6:167658907-167658957	GM12892	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:167662732..167663315-chr6:167819023..167819880,2	K562	blood:
2	chr6:167668192..167671777-chr6:167684157..167687082,3	K562	blood:
3	chr6:167669951..167671777-chr6:167683631..167687000,3	K562	blood:
4	chr6:167662535..167665478-chr6:167668701..167671430,2	K562	blood:
5	chr6:167662535..167665478-chr6:167668701..167671430,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UNC93A-1	chr6:167659275-167659404	XLOC_005540

Variant related genes	Relation type
ENSG00000231720	TF binding region
ENSG00000231720	CpG island
ENSG00000112494	chromatin interactions

Extended variants
information (count: 957 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:957 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs182315644	chr6:167658277-167658278	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs563627639	chr6:167658324-167658325	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs141795548	chr6:167658429-167658430	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs57839822	chr6:167658508-167658509	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs550767045	chr6:167658594-167658595	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs559038921	chr6:167658598-167658599	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs533296085	chr6:167658626-167658627	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs551742167	chr6:167658654-167658655	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs566573166	chr6:167658655-167658656	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs9457294	chr6:167658783-167658784	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs186400423	chr6:167658785-167658786	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs9356577	chr6:167658802-167658803	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs535616603	chr6:167658836-167658837	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs74653319	chr6:167658871-167658872	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs34177448	chr6:167658875-167658876	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs575288446	chr6:167658919-167658920	Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs545629064	chr6:167659006-167659007	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs374537690	chr6:167659014-167659015	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs36015563	chr6:167659034-167659035	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs529688058	chr6:167659050-167659051	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs572887403	chr6:167659082-167659083	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs540896146	chr6:167659083-167659084	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs547248076	chr6:167659084-167659085	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs6917883	chr6:167659088-167659089	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs529586008	chr6:167659105-167659106	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs544773576	chr6:167659175-167659176	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs376900962	chr6:167659192-167659193	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs147581811	chr6:167659194-167659195	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs6903410	chr6:167659318-167659319	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs115260480	chr6:167659351-167659352	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs551464292	chr6:167659352-167659353	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs6918389	chr6:167659377-167659378	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs116561501	chr6:167659387-167659388	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs548995412	chr6:167659390-167659391	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs567999180	chr6:167659396-167659397	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs535425041	chr6:167659429-167659430	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs550749404	chr6:167659430-167659431	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs368494462	chr6:167659501-167659502	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs569664564	chr6:167659522-167659523	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs568964492	chr6:167659546-167659547	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs190764633	chr6:167659547-167659548	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs554969005	chr6:167659553-167659554	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs113531553	chr6:167659563-167659564	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs111399190	chr6:167659566-167659567	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs113387062	chr6:167659575-167659576	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs574263600	chr6:167659591-167659592	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs187426005	chr6:167659702-167659703	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs35686527	chr6:167659709-167659710	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs190315246	chr6:167659724-167659725	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs73269455	chr6:167659727-167659728	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:132 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167650000-167658400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr6:167654800-167664800	Weak transcription	Right Atrium	heart
3	chr6:167655200-167660000	Enhancers	Fetal Brain Male	brain
4	chr6:167655600-167659000	Enhancers	HepG2	liver
5	chr6:167655600-167660600	Enhancers	Fetal Muscle Leg	muscle
6	chr6:167656400-167658600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
7	chr6:167656800-167661000	Weak transcription	Fetal Intestine Small	intestine
8	chr6:167657200-167659200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr6:167657200-167660200	Enhancers	H1 Cell Line	embryonic stem cell
10	chr6:167657200-167660200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr6:167657400-167658200	Flanking Active TSS	Fetal Brain Female	brain
12	chr6:167657400-167658600	Enhancers	Brain Germinal Matrix	brain
13	chr6:167657400-167660000	Enhancers	H9 Cell Line	embryonic stem cell
14	chr6:167657600-167658200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr6:167657600-167658400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr6:167657600-167658400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
17	chr6:167657600-167658600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr6:167657600-167658600	Enhancers	Fetal Thymus	thymus
19	chr6:167657600-167659000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr6:167657600-167659000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
21	chr6:167657600-167659200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
22	chr6:167657600-167659200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr6:167657800-167658200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
24	chr6:167657800-167658600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr6:167657800-167658800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr6:167657800-167659000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr6:167657800-167659000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr6:167657800-167659000	Enhancers	Cortex derived primary cultured neurospheres	brain
29	chr6:167657800-167659400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
30	chr6:167658000-167659200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr6:167658000-167662200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr6:167658200-167659400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr6:167658200-167660400	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr6:167658200-167660600	Enhancers	Fetal Brain Female	brain
35	chr6:167658400-167658800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr6:167658400-167658800	Enhancers	iPS-15b Cell Line	embryonic stem cell
37	chr6:167658400-167661200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr6:167658600-167658800	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr6:167658600-167660400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
40	chr6:167658600-167661200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr6:167658800-167659000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
42	chr6:167658800-167659000	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
43	chr6:167659000-167659800	Enhancers	iPS-18 Cell Line	embryonic stem cell
44	chr6:167659000-167660000	Enhancers	HUES48 Cell Line	embryonic stem cell
45	chr6:167659000-167660000	Enhancers	iPS-15b Cell Line	embryonic stem cell
46	chr6:167659000-167660200	Enhancers	ES-I3 Cell Line	embryonic stem cell
47	chr6:167659000-167661200	Weak transcription	HepG2	liver
48	chr6:167659200-167659800	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr6:167659200-167661200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr6:167659400-167660000	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links